Peptide containing 31 amino acids with inhibin-like activity.

Used to test a theory of molecular recognition.

A passive immunotherapeutic agent for cytomegalovirus (CMV) infection; developed by Teijin Ltd.

NCI: Early- to late-stage myeloid progenitor cells derived from adult human stem cells with potential hematopoietic activity. Upon infusion, human myeloid progenitor cells CLT-008 proliferate into mature myeloid cells, including granulocytes, macrophages, platelets, and erythrocytes. These myeloid progenitor cells die within forty-five days after a burst of hematopoiesis. This agent cannot create lymphoid cells, including T cells associated with graft-versus-host disease (GVHD). (NCI Thesaurus)

A type of ALPHAPAPILLOMAVIRUS usually associated with GENITAL WARTS; and LARYNGEAL NEOPLASMS.

Vaccine containing L1 capsid proteins from types 16 and 18 of HPV (ALPHAPAPILLOMAVIRUS).